In a collaborative breakthrough, scientists from Hyderabad's CCMB and IISER Kolkata have developed metal-based compounds capable of selectively targeting and destroying triple-negative breast cancer cells. The discovery marks a significant step in developing treatments for aggressive and treatment-resistant forms of breast cancer.
